SMFKY Stock DD Smurfit Kappa Group Plc 08/10/2014 21:44:08

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
SMFKY Smurfit Kappa Group Plc $SMFKY Company Overview

Stock Message Board Recent Posts http://investorshangout.com/search?q=SMFKY&am...mp;yt0=Go!

Last Updated: 08/10/2014 21:44:03

Current Price and Quotes
Last Price 44.21
Previous Close 43.75 Open 44.21
Daily Range N/A - 44.21 52wk Range 40.68 - 55.96
Volume 280 Dividend 0.6266
Average Vol (30d) 6,638 Yield 1.4173




Financials
Period Ending
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses

Research and Development
Sales, General and Admin.
Non-Recurring Items
Other
Operating Income
Income From Continuing Operations

Add'l Income/Expense Items
Earnings Before Interest and Tax
Interest Expense
Earnings Before Tax
Income Tax
Minority Interest
Equity Earnings Unconsolidated Subsidiary
Net Income Cont. Operations
Non Recurring Events

Discontinued Operations
Extraordinary Items
Effect of Accounting Changes
Other Items
Net Income
Preferred Stock and Other Adjustments
Net Income Applicable to Common Shareholders
Recent News


SMFKY Smurfit Kappa Group Plc Research DD Guide

Stock Message Board http://investorshangout.com/search?q=SMFKY&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/SMFKY/quote
Stock Chart http://www.otcmarkets.com/stock/SMFKY/chart
Company Info http://www.otcmarkets.com/stock/SMFKY/company-info
Recent News http://www.otcmarkets.com/stock/SMFKY/news
Financials http://www.otcmarkets.com/stock/SMFKY/financials
Filings and Disclosure http://www.otcmarkets.com/stock/SMFKY/filings
Short Sales http://www.otcmarkets.com/stock/SMFKY/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/SMFKY/insider-transactions
Research Reports http://www.otcmarkets.com/stock/SMFKY/research
Summary http://finance.yahoo.com/q?s=SMFKY
Historical Prices http://finance.yahoo.com/q/hp?s=SMFKY+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=SMFKY
Basic Chart http://finance.yahoo.com/q/bc?s=SMFKY+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=SMFKY+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=SMFKY+Headlines
Press Releases http://finance.yahoo.com/q/p?s=SMFKY+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=SMFKY+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=SMFKY+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=SMFKY+Industry
Major Holders http://finance.yahoo.com/q/mh?s=SMFKY+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=SMFKY+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=SMFKY+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=SMFKY
Balance Sheet http://finance.yahoo.com/q/bs?s=SMFKY
Cash Flow http://finance.yahoo.com/q/cf?s=SMFKY+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/SMFKY
Market Watch http://www.marketwatch.com/investing/stock/SMFKY
Bloomberg http://www.bloomberg.com/quote/SMFKY:US
Morningstar http://quotes.morningstar.com/stock/s?t=SMFKY
Bussinessweek http://investing.businessweek.com/research/st...cker=SMFKY
Barchart http://www.barchart.com/quotes/stocks/SMFKY
OTC Short Report http://otcshortreport.com/index.php?index=SMFKY
Investopedia http://www.investopedia.com/markets/stocks/SMFKY/?wa=0
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Klarna’s Cash Burn Puts Disclosure Questions in Focus

Updated Category News Views 76

A $383 million operating cash drain can turn a growth story sour in a hurry. Klarna Group plc delivered exactly that kind of unpleasant jolt in its third-quarter 2026 report: a net loss of $65 million, or roughly $0.19 per share, alongside negative operating cash flow of $383 million over the first nine months of 2026. The per-share loss landed worse than the $0.13 to...

Continue Reading
Gene Editing’s Steady Revenue Engine Is Taking Shape

Updated Category News Views 112

Gene editing is finally starting to look less like a science-fair moonshot and more like a working supply chain. That distinction matters. The latest market estimate puts the global gene editing market at $5.23 billion in 2026 and projects $8.49 billion by 2031, a 10.1% compound annual growth rate. Respectable growth, certainly, but the real investment story is not a...

Continue Reading
LianLian XWorker Brings AI Agents Into Global Payments

Updated Category News Views 110

Most AI launches promise a clever helper; this one wants the helper holding a tightly controlled wallet. Lianlian DigiTech unveiled LianLian XWorker at Singapore FinTech Festival 2026 on November 19, pitching an AI Workforce platform that joins task-running agents with its global financial plumbing. That is a much more consequential proposition than another chatbot that...

Continue Reading
RUDSAK Tests Premium Demand From Toronto to New York

Updated Category News Views 145

A coat rack on Bloor Street can tell a harsher story than a glossy expansion announcement. RUDSAK has opened a Toronto flagship at 55 Bloor Street West in the Manulife Centre and is preparing a boutique at American Dream outside New York City. This is a real step up in retail ambition for the Montréal luxury outerwear house, founded in 1994, and it deserves more than the...

Continue Reading
Adcendo’s Early Sarcoma Data Earns a Careful Look

Updated Category News Views 71

Sarcoma data rarely gives anyone permission to pound the table, yet Adcendo’s first look at ADCE-D01 deserves more than a polite nod. In advanced soft tissue sarcoma, where patients have often run through the usual options and second-line response rates historically sit around 4% to 10%, a reported 30% objective response rate on the every-two-week schedule is...

Continue Reading
Compounded Peptides Demand Clearer FDA Status Answers

Updated Category News Views 73

Peptide talk has gotten muddled enough to make plain English feel revolutionary. The central point in the HelloNation article featuring wellness expert Andres Giraldo is straightforward: a compounded peptide is not FDA approved in the same product-specific manner as a commercially manufactured drug. That is not a small semantic wrinkle, and it should not be buried beneath...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 43

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
Dental Exams Are Routine Until They Catch Something Early

Updated Category News Views 60

A mouth can look perfectly fine right up until it does not. That is the unglamorous value in the dental exam and X-rays visit described by Dr. Eric Runyon of Smiles Unlimited in Belton, Missouri: it is a structured look for trouble before pain, swelling, or a cracked tooth forces the issue. Nobody throws a parade for preventive care, but waiting for symptoms has a habit...

Continue Reading
Institutions Spread AI Bets as 2027 Risks Mount Higher

Updated Category News Views 89

Money managers are not fleeing the party; they are checking the fire exits. Natixis Investment Managers surveyed 515 institutions overseeing $42.7 trillion, and their 2027 posture is pretty plain: keep taking risk, just stop pretending every risk is the same. Inflation, rates, government debt, geopolitical fracture and an AI spending boom are all tugging at portfolios at...

Continue Reading
Lowe's Dec. 9 Conference Puts Strategy on the Clock

Updated Category News Views 148

A Calendar Entry With Real Weight December 9 is not earnings day, but it is the sort of date shareholders ought to circle anyway. Lowe's plans to hold its 2026 Analyst and Investor Conference at 8 a.m. Eastern time in New York City, with a live webcast available for those not sitting in the room. For owners of NYSE:LOW, these gatherings can be more useful than the usual...

Continue Reading
es